A detailed history of Atlantic Private Wealth, LLC transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Atlantic Private Wealth, LLC holds 1,000 shares of SGMO stock, worth $1,040. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,000
Previous 2,500 60.0%
Holding current value
$1,040
Previous $2,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025

SELL
$0.78 - $2.87 $1,170 - $4,305
-1,500 Reduced 60.0%
1,000 $1,000
Q3 2024

Nov 07, 2024

BUY
$0.32 - $1.1 $800 - $2,750
2,500 New
2,500 $2,000

Others Institutions Holding SGMO

About SANGAMO THERAPEUTICS, INC


  • Ticker SGMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 156,552,992
  • Market Cap $163M
  • Description
  • Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...
More about SGMO
Track This Portfolio

Track Atlantic Private Wealth, LLC Portfolio

Follow Atlantic Private Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlantic Private Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atlantic Private Wealth, LLC with notifications on news.